“The apprehension with working with non IID detailed ingredients is justified as it truly is difficult To judge if FDA would find the ‘novel excipient’ Harmless to be used in a drug solution as there isn't a outlined course of action for evaluation and acceptance of excipients. The FDA https://proleviate.com/